Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: September 2021

Workgroups: Maternal, Infant, and Child Health Workgroup

The U.S. Preventive Services Task Force recommends the use of low-dose aspirin to prevent preeclampsia in people who are more than 12 weeks pregnant and are at high risk for preeclampsia. Low-dose aspirin is 81 mg daily.

Read more about this resource

Objectives related to this resource (1)

Reduce maternal deaths — MICH‑04
LHI label
Getting worse

Suggested Citation

1.

U.S. Preventive Services Task Force. (2021). Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication